The Europe CBD oil market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 23% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.
Cannabidiol (CBD) refers to a non-psychoactive compound extracted from leaves, resin, and flowers of the marijuana or hemp (cannabis) plant. CBD oil is mainly produced by extracting CBD from the cannabis plant and further diluting it with a carrier oil, such as coconut or hemp seed oil. The oil is widely adopted for numerous medicinal purposes due to the absence of psychoactive effects, such as reducing depression, relieving pain, improving heart health, alleviating cancer-related symptoms, treating acne, etc.
The rising legalization of cannabidiol across several European countries is propelling the market for CBD oil. The growing prevalence of various neurological and psychiatric ailments is also driving the demand of CBD oil for treating insomnia, reducing anxiety, minimizing stress levels, improving seizures, etc. In line with this, CBD oil-infused supplements are also adopted in cancer treatment for relieving adverse health effects of chemotherapy, such as inflammation, nausea, insomnia, weight loss, etc. Moreover, significant growth in the pharmaceutical industry along with the increasing use of bioactive ingredients in drugs is further catalyzing the use of CBD oil based on its high content of iron, protein, fiber, zinc, etc. Additionally, the expanding utilization of CBD oil in the cosmetics and personal care sectors based on its antioxidation, anti-aging, and anti-inflammatory properties is also augmenting the market growth in the region. In the coming years, the rising investments by several private and government organizations in extensive R&D activities for cannabinoids will continue to drive the CBD oil market in Europe.
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe CBD oil market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, source, product type, product category, application and distribution channel.
Breakup by Source:
Breakup by Product Type:
Breakup by Product Category:
Breakup by Application:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined with some of the key players being Aurora Cannabis, Diamond CBD Inc., ENDOCA, APHRIA Inc., ConnOils LLC, Elixinol Global Limited, Emblem CANNABIS, NuLeaf Naturals, LLC, CBD Ultra Limited and The Original Alternative Limited.
|Base Year of the Analysis||2020|
|Segment Coverage||Source, Product Type, Product Category, Application, Distribution Channel, Country|
|Countries Covered||Germany, Spain, Italy, France, United Kingdom, Russia|
|Companies Covered||Aurora Cannabis, Diamond CBD Inc., ENDOCA, APHRIA Inc., ConnOils LLC, Elixinol Global Limited, Emblem CANNABIS, NuLeaf Naturals, LLC, CBD Ultra Limited and The Original Alternative Limited.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at